abrdn plc Purchases Shares of 708,303 Pyxis Oncology, Inc. (NASDAQ:PYXS)

abrdn plc acquired a new position in Pyxis Oncology, Inc. (NASDAQ:PYXS – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund acquired 708,303 shares of the company’s stock, valued at approximately $1,275,000. Several other large investors have also recently modified their […]

Related Keywords

Canada ,Leerink Partnrs ,Pyxis Oncology Inc ,Exchange Commission ,Nasdaq ,Schulhoff Co ,Commonwealth Equity Services ,Acadian Asset Management ,Royal Bank ,Pyxis Oncology ,Free Report ,Equity Services ,Asset Management ,Decheng Capital Management ,Get Free Report ,Visit Holdingschannel ,Pyxis Oncology Daily ,Nasdaq Pyxs ,Pyxs ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,